Related Experiment Video
Updated: May 25, 2026
09:24
Expanding the Toolkit for In Vivo Imaging of Axonal Transport
Published on: December 23, 2021
Cargo distributions differentiate pathological axonal transport impairments.
Cassie S Mitchell1, Robert H Lee
1Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University School of Medicine, Atlanta, GA 30332, USA. cassie.mitchell@bme.gatech.edu
Journal of Theoretical Biology
|January 31, 2012
Summary
This study identifies unique "signatures" of axonal transport impairments caused by motor depletion, motor dilution, or protein aggregation. These findings help diagnose transport defects in neurodegenerative diseases like ALS.
Area of Science:
- Neuroscience
- Computational Biology
- Biophysics
Background:
- Axonal transport is crucial for neuronal function, supplying energy and building materials while removing waste.
- Impaired axonal transport is implicated in severe neurodegenerative diseases, including ALS, Huntington's, and Alzheimer's.
- Current challenges in treatment development stem from the inability to identify specific axonal transport impairment types in diseases.
Purpose of the Study:
- To develop a computational model to identify distinct characteristics or "signatures" of axonal transport impairments.
- To differentiate between three primary types of axonal transport defects: motor depletion, motor dilution, and protein aggregation.
- To provide a method for analyzing experimental and clinical data to elucidate axonal transport impairments.
Main Methods:
- Utilized a computational model to simulate axonal transport dynamics.
- Applied common experimental metrics to analyze simulation outputs.
- Correlated model-predicted signatures with known defect types.
Main Results:
- Successfully identified unique "signatures" for motor depletion, motor dilution, and protein aggregation.
- Revealed emergent dynamic features of axonal transport that may underlie multiple impairment types.
- Demonstrated the model's ability to predict likely defect candidates in disease models, exemplified by the G93A SOD1 mouse model of ALS.
Conclusions:
- The developed analytical method and identified signatures can distinguish between general axonal transport impairment types.
- This approach offers a valuable tool for diagnosing transport defects in neurodegenerative conditions.
- The findings contribute to understanding the complex dynamics of axonal transport and its role in disease pathogenesis.
Related Concept Videos
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
01:21Neurons: The Axon
Axons are long, cytoplasmic processes of nerve cells capable of propagating electrical impulses known as action potentials. The cytoplasm or axoplasm of an axon contains neurofibrils, neurotubules, small vesicles, lysosomes, mitochondria, and various enzymes, all encased within the axolemma, the plasma membrane of the axon.
The axon attaches to the cell body at a cone-shaped elevation called the axon hillock. The initial part of the axon, closest to the hillock, is known as the initial segment.
The axon attaches to the cell body at a cone-shaped elevation called the axon hillock. The initial part of the axon, closest to the hillock, is known as the initial segment.
01:06Carrier-Mediated Transport
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
01:26Transport Across the Golgi
While it is unclear how molecules move between adjacent Golgi cisternae, it is apparent that the molecules move from cis- cisterna, the entry face, to the trans- cisterna, the exit face. Experiments initially suggested vesicles that bud from one cisterna and fuse with the next cisterna to transport proteins between the cisternae. This vesicular transport model describes the Golgi apparatus as a relatively static structure with a unique enzyme composition in each cisterna. Molecules are...